BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7908361)

  • 1. Congenital anaemia after transplacental B19 parvovirus infection.
    Brown KE; Green SW; Antunez de Mayolo J; Bellanti JA; Smith SD; Smith TJ; Young NS
    Lancet; 1994 Apr; 343(8902):895-6. PubMed ID: 7908361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin.
    Matsuda H; Sakaguchi K; Shibasaki T; Takahashi H; Kawakami Y; Furuya K
    J Perinat Med; 2005; 33(6):561-3. PubMed ID: 16318623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after intrauterine parvovirus B19 infection with persistence in early infancy: a two-year follow-up.
    Donders GG; Van Lierde S; Van Elsacker-Niele AM; Moerman P; Goubau P; Vandenberghe K
    Pediatr Infect Dis J; 1994 Mar; 13(3):234-6. PubMed ID: 8177636
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrauterine anemia due to parvovirus B19: successful treatment with intravenous immunoglobulins.
    Rugolotto S; Padovani EM; Sanna A; Chiaffoni GP; Marradi PL; Borgna-Pignatti C
    Haematologica; 1999 Jul; 84(7):668-9. PubMed ID: 10406919
    [No Abstract]   [Full Text] [Related]  

  • 5. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection.
    Fairley CK; Smoleniec JS; Caul OE; Miller E
    Lancet; 1995 Nov; 346(8986):1335-7. PubMed ID: 7475774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus infection of the human fetus and newborn.
    Berry PJ; Gray ES; Porter HJ; Burton PA
    Semin Diagn Pathol; 1992 Feb; 9(1):4-12. PubMed ID: 1561488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of epidemiology and fetal effects of human parvovirus B19 infection].
    Oka H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jun; 45(6):533-9. PubMed ID: 8315312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection.
    Morey AL; Porter HJ; Keeling JW; Fleming KA
    J Clin Pathol; 1992 Aug; 45(8):673-8. PubMed ID: 1401175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 infection in pregnancy.
    Crane J; Mundle W; Boucoiran I;
    J Obstet Gynaecol Can; 2014 Dec; 36(12):1107-1116. PubMed ID: 25668048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 infection in a twin pregnancy.
    Pustilnik TB; Cohen AW
    Obstet Gynecol; 1994 May; 83(5 Pt 2):834-6. PubMed ID: 8159367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of parvovirus B19 in fetal autopsies.
    Schwarz TF; Nerlich A; Hillemanns P
    Arch Gynecol Obstet; 1993; 253(4):207-13. PubMed ID: 8161255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A report of human parvovirus B19 infection in hydrops fetalis. First Australian cases confirmed by serology and immunohistology.
    Moore L; Chambers HM; Foreman AR; Khong TY
    Med J Aust; 1993 Sep; 159(5):344-5. PubMed ID: 8361433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fetal erythropoiesis and parvovirus B19].
    Morinet F
    Pathol Biol (Paris); 1992 Sep; 40(7):711-3. PubMed ID: 1480406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital anemia caused by parvovirus B19 infection.
    Heegaard ED; Hasle H; Skibsted L; Bock J; Brown KE
    Pediatr Infect Dis J; 2000 Dec; 19(12):1216-8. PubMed ID: 11144391
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis.
    Bascietto F; Liberati M; Murgano D; Buca D; Iacovelli A; Flacco ME; Manzoli L; Familiari A; Scambia G; D'Antonio F
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):569-576. PubMed ID: 29785793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical transplacental parvovirus B19 infection: an increased fetal risk?
    Smoleniec JS; Pillai M; Caul EO; Usher J
    Lancet; 1994 Apr; 343(8905):1100-1. PubMed ID: 7909117
    [No Abstract]   [Full Text] [Related]  

  • 17. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy.
    Koch WC; Harger JH; Barnstein B; Adler SP
    Pediatr Infect Dis J; 1998 Jun; 17(6):489-94. PubMed ID: 9655540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B19 parvovirus.
    Young NS
    Baillieres Clin Haematol; 1995 Mar; 8(1):25-56. PubMed ID: 7663050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal hydrops secondary to human parvovirus infection in early pregnancy.
    Petrikovsky BM; Baker D; Schneider E
    Prenat Diagn; 1996 Apr; 16(4):342-4. PubMed ID: 8734809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of interferon alfa-2a for persistent parvovirus B19 infection.
    Mogensen TH; Skouboe MK; Mølle I
    Lancet Infect Dis; 2023 Apr; 23(4):e160-e165. PubMed ID: 36436534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.